A Case of Sequential Development of Polymyalgia Rheumatica and Guillain-Barré Syndrome Following Administration of the Pfizer-BioNTech COVID-19 Vaccine.

Yamada, Shunsuke; Yamada, Kanako; Nishida, Hiroshi

Yamada, Shunsuke; Yamada, Kanako; Nishida, Hiroshi.

Yamada S; Nishida Hospital, Japan.
Yamada K; Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Japan.
Nishida H; Nishida Hospital, Japan.

Intern Med ; 61(19): 2995, 2022 10 01.

Article in English | MEDLINE | ID: covidwho-2054684

Subject(s)

COVID-19; Giant Cell Arteritis; Guillain-Barre Syndrome; Influenza Vaccines; Polymyalgia Rheumatica; BNT162 Vaccine; Guillain-Barre Syndrome/chemically induced; Humans

Keywords

COVID-19; Guillain-Barré syndrome; polymyalgia rheumatica; vaccine

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Polymyalgia Rheumatica / Giant Cell Arteritis / Influenza Vaccines / Guillain-Barre Syndrome / COVID-19 Type of study: Case report Topics: Vaccines Limits: Humans Language: English Journal: Intern Med Journal subject: Internal Medicine Year: 2022 Document Type: Article Affiliation country: Internalmedicine.0319-22

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google